Skip to main content
Equibles
GEHC logo

GEHC · GE HealthCare Technologies Inc. · Metrics

Track GEHC — free

Use GEHC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GEHC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$71.98 +0.53 (+0.74%) At close · Oct 26
S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$32.50B
Shares
454.89M
Volume · Oct 26 2.87M Avg daily vol (3M) 3.64M

GEHC metrics

102 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$71.98
Market cap
$32.50B

Price action

20 metrics
Price change (1W)
+2.7%
Price change (30D)
+7.0%
Price change (3M)
+17.9%
Price change (6M)
+3.8%
Price change (YTD)
-12.9%
Price change (1Y)
-7.5%
Trailing year
Price change (5Y)
—
52-week high
$88.16
52-week low
$59.49
Change from 52-week high
-19.0%
Change from 52-week low
+20.1%
Annualized volatility
34.7%
Annualized volatility (3M)
35.1%
Beta
0.7
RSI (14D)
64.6
Price vs SMA 50
+4.5%
Price vs SMA 200
+1.9%
Avg volume (3M)
3.74M
Relative volume
0.8
Average dollar volume
$254.02M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
454.89M

Valuation

12 metrics
P / E (TTM)
16.4
Trailing earnings · reciprocal yield 6.1%
PEG ratio
1.0
EV / revenue
1.9×
reciprocal yield 52.5%
EV / EBITDA
—
EV / EBIT
14.8×
reciprocal yield 6.7%
P / sales
1.5×
reciprocal yield 65.4%
P / book
3.0
reciprocal yield 33.8%
FCF yield
—
TTM · current market cap
Buyback yield
1.2%
P / FCF
—
P / operating cash flow
15.5
reciprocal yield 6.5%
Earnings yield
6.1%

Historical valuation

8 metrics
P / E historical average (3Y)
19.4×
reciprocal yield 5.2%
P / E historical average (5Y)
19.4×
reciprocal yield 5.2%
EV / revenue historical average (3Y)
2.1×
reciprocal yield 47.4%
EV / revenue historical average (5Y)
2.1×
reciprocal yield 47.4%
EV / EBIT historical average (3Y)
16.2×
reciprocal yield 6.2%
EV / EBIT historical average (5Y)
16.2×
reciprocal yield 6.2%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.2%
Trailing 12 months
Payout ratio
3.2%
Shareholder yield
1.4%
Dividend / share (TTM)
$0.15
Dividend growth YoY
+3.6%
Dividend growth streak
2
Last ex-dividend
2026-10-23

Earnings calendar

2 metrics
Next earnings
2026-10-28
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
39.5%
Operating margin
12.9%
Trailing 12 months
Net margin
9.3%
Gross profit (TTM)
$8.41B
Operating profit (TTM)
$2.73B
Net income (TTM)
$1.98B
Trailing 12 months
Diluted EPS (TTM)
$4.35
FCF margin
—
Effective tax rate
22.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$46.58
Gross profit per diluted share (TTM)
$18.42
Operating profit per diluted share (TTM)
$5.99
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$4.35
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
$1.14
R&D per diluted share (TTM)
$2.81
Stock compensation per diluted share (TTM)
$0.34
Book value per share
$15.67

Growth

11 metrics
Revenue growth YoY
+5.8%
Year over year
Net income growth YoY
+15.4%
Revenue (TTM)
$21.27B
Trailing 12 months
EPS growth YoY
+17.0%
Shares change YoY
-0.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+4.0%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
+2.5%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-6.2%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
18.1%
Return on assets
5.3%
Debt / equity
0.9
Current ratio
1.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
11.1%
Trailing 12 months
Net cash
−$8.01B
Latest balance sheet
Cash & equivalents
$2.08B
Total assets
$37.25B
Total debt
$10.09B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.10B
Capital expenditures (TTM)
$522.00M
R&D (TTM)
$1.28B
SG&A (TTM)
$4.39B
Stock compensation (TTM)
$154.00M
R&D / revenue
6.0%
Stock compensation / revenue
0.7%

Ownership (13F)

9 metrics
13F filers
1,239
13F filer change QoQ
-43
Institutional ownership
87.6%
Conviction holders (share of 13F filers)
0.6%
Crowding (high-turnover and private-fund holders)
27.5%
Private-fund adviser ownership
27.1%
Active holders' share change QoQ
-2.9%
Holder tenure
10.2
Price vs estimated holder cost
-13.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
22.3%

Short interest

3 metrics
Short interest
4.3%
Latest settlement · 5.1 days to cover
Days to cover
5.1d
Short-squeeze score
74 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1932393 CUSIP 36266G107 13F (30d) 318 filings 292 filers Visit website Investor relations